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Increasing numbers of bacterial strains being resistant to conventional antibiotics emphasize the urgent need for new antimicrobial agents. One
strategy is based on host defence peptides that can be found in every organism including humans. We have studied the antimicrobial peptide LF11,
derived from the pepsin cleavage product of human lactoferrin, known for its antimicrobial and lipid A-binding activity, and peptide C12LF11, the
N-lauryl-derivative of LF11, which has owing to the attached hydrocarbon chain an additional hydrophobic segment. The influence of this
hydrocarbon chain on membrane selectivity was studied using model membranes composed of dipalmitoylphosphatidylglycerol (DPPG),
mimicking bacterial plasma membranes, and of dipalmitoylphosphatidylcholine (DPPC), a model system for mammalian membranes. A variety of
biophysical techniques was applied. Thereby, we found that LF11 did not affect DPPC bilayers and showed only moderate effects on DPPG
membranes in accordance with its non-hemolytic and weak antimicrobial activity. In contrast, the introduction of the N-lauryl group caused
significant changes in the phase behaviour and lipid chain packing in both model membrane systems. These findings correlate with the in vitro
tests on methicillin resistant S. aureus, E. coli, P. aeruginosa and human red blood cells, showing increased biological activity of C12LF11
towards these test organisms. This provides evidence that both electrostatic and hydrophobic interactions are crucial for biological activity of
antimicrobial peptides, whereas a certain balance between the two components has to be kept, in order not to loose the specificity for bacterial
membranes.
© 2006 Elsevier B.V. All rights reserved.Keywords: Acylation and antimicrobial peptide; Lactoferrin; Antimicrobial and hemolytic activity; Model membrane1. Introduction
Growing concern about the increase of bacterial strains being
resistant against conventional antibiotics has spurred research
on alternative agents, in particular on peptide antibiotics, which
play an important role in the innate immune system [1–4].
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doi:10.1016/j.bbamem.2006.02.032which are often formed only during their contact with
membranes. They are cationic, a property that is believed to
form the basis for their partial or complete selectivity against
negatively charged bacterial membranes [5–8]. Furthermore,
studies on e.g. pardaxin, which exhibits antimicrobial activity
and is toxic at high concentrations, indicated that peptides may
exert different membrane disrupting mechanisms depending on
the lipid composition [9]. Considering the diversity of lipids in
cell membranes, it may not be too surprising that different
mechanisms of action have evolved in nature [10]. Thus, one
major issue in the quest for novel peptide antibiotics is to find
peptides with high activity against prokaryotic cells and low
toxicity towards eukaryotic cells. While many such peptides
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bacteria remains so far largely unclear [10].
One example of naturally occurring antimicrobial peptides is
lactoferricin (LFcin) [11,12]. LFcin is a pepsin cleavage
fragment from lactoferrin (LF), a multifunctional iron-binding
glycoprotein originally discovered in bovine milk [13] and later
in exocrine secretions of mammals, as well as in granules and
neutrophils during inflammatory responses [14,15]. Bovine
LFcin contains a region that forms an amphipathic α-helix, but
when isolated, this peptide fragment folds into a β-hairpin
structure [16,17]. Human lactoferricin (hLFcin) comprises
amino acid residues 1–45 of the N-terminus of human
lactoferrin (hLF) and has enhanced antibacterial activity as
compared to intact hLF [18]. Unlike bovine LFcin the longer
hLFcin displays a nascent helical structure (Gln14–Lys29) that
is better stabilized in membrane mimetic systems [19]. LFcin
inhibits growth of a diverse range of microorganisms like Gram-
negative bacteria, Gram-positive bacteria, and yeast filamentous
fungi, including some antibiotic resistant pathogens [20]. It is
supposed to kill the target organisms by membrane permeabi-
lization and suppresses the activation of innate immunity by
microbial components such as lipopolysaccharides [20]. To help
identify the ‘antimicrobial principle’ in LF, derivatives have
been constructed and a wealth of data have been collected to
gain insight into the mode of antibacterial action of LF [12,17].
Furthermore, it was shown in particular for helical peptides that
antimicrobial activity is not only controlled by the overall
charge but also by the hydrophobicity of the peptides [21–23].
Therefore one of the strategies to improve antimicrobial activity
may be the attachment of a hydrophobic chain that can
compensate for lack of hydrophobicity [24]. In fact, Wakabaya-
shi et al. [20,25] and Strom et al. [26] have shown that N-
acylation of derivatives based on a sequence of bovine
lactoferricin B (amino acids 17–41) resulted in higher
antibacterial activity. However, such strategy usually leads to
a higher toxicity towards eukaryotic cells, thus resulting in loss
of target cell selectivity [24,27].
Therefore, we studied the effect of both LF11, an 11-residue
fragment of hLF, and its N-lauryl-derivative, C12LF11, on
membrane mimetic systems in order to gain information on the
role of hydrophobic attachment for membrane selectivity. These
peptides were selected based on previous studies demonstrating
that the insertion of a 12 hydrocarbon chain at the C-terminal or
N-terminal region of LF11 leads to the strongest enhancement
in antibacterial activity and binding of lipopolysaccharide
[28,29], therefore improving its potential therapeutic use to
combat the harmful effects of sepsis [30]. The 11 amino acid
stretching peptide LF11 comprises amino acid 21–31 of hLF,
whereas methionine at position seven has been exchanged by an
isoleucine to prevent oxidation.
Cell membranes contain a variety of lipid classes but
depending on the species a common pattern can be seen: The
cytoplasmic membrane of Gram-negative bacteria consists
mainly of PE (phosphatidylethanolamine), PG (phosphatidyl-
glycerol) and CL (cardiolipin), while Gram-positive bacteria
have a large amount of PG and derivatives in their lipid bilayer
membrane [7]. The plasma membrane of red blood cells, in turn,is comprised to a large amount (60%) of phospholipids and
about 25% of cholesterol. Choline phosphatides (PC (phospha-
tidylcholine) and SM (sphingomyelin)) are the main compo-
nents of the outer leaflet of mammalian red blood cell plasma
membranes [7]. Accordingly, we have selected negatively
charged 1,2-dipalmitoylphosphatidylglycerol (DPPG) as a
model membrane system for bacterial membranes and 1,2-
dipalmitoylphosphatidylcholine (DPPC) to mimic mammalian
plasma membranes.2. Materials and methods
2.1. Reagents
1,2-Dipalmitoylphosphatidylglycerol (Na-salt) (DPPG) and 1,2- dipalmi-
toylphosphatidylcholine (DPPC) were purchased from Avanti Polar Lipids,
Inc. (USA), and used without further purification. Purity (>99%) was checked
before and after experiments by thin layer chromatography showing a single
spot using CHCl3/CH3OH/NH3 (25% in water) (65:25:5, v/v) as mobile
phase and detection with a phosphorus-sensitive reagent (molybdenic acid,
[31]). Stock solutions of DPPC were prepared in CHCl3/CH3OH (2:1, v/v),
while DPPG was dissolved in CHCl3/CH3OH/H2O (9:1:0.01, v/v) and stored at
−18 °C.
The peptides, LF11 (FQWQRNIRKVR-NH2, M=1529.8 g/mol) and its N-
lauryl derivative (C12LF11, (CH3-(CH2)10-CO-NH-FQWQRNIRKVR-NH2,
M=1712.1 g/mol) were purchased from NeoMPS, Inc. (San Diego, CA, USA).
The purities were >96% as determined by RP-HPLC. LF11 was dissolved in
phosphate buffered saline (PBS, 20 mM NaPi, 130 mM NaCl, pH 7.4) at a
concentration of 3 mg/ml. C12LF11 was dissolved in CHCl3/CH3OH (1:2, v/v)
at a concentration of 1 mg/ml. The peptide solutions were prepared freshly for
each experiment.2.2. Assays for antimicrobial and hemolytic activity
Antimicrobial activity of the peptides was tested using susceptibility
microdilution assays according to NCCLS (National Committee for Clinical
Laboratory Standards) approved guidelines. Briefly, a suspension of log-phase
bacteria in Mueller–Hinton broth was added to serial dilutions of the peptide
solution in microtiter plates that were subsequently incubated overnight at
37 °C. The bacterial growth was monitored to determine the minimal inhibitory
concentration, MIC [32].
The hemolytic activity towards human red blood cells, which were obtained
from heparinized human blood, was determined by the release of haemoglobin
following an hour incubation at 37 °C [32]. Total release of haemoglobin was
achieved by adding Triton X-100 (0.5% final concentration).2.3. Preparation of liposomes
Appropriate amounts of the phospholipid stock solutions were dried under a
stream of nitrogen and stored in vacuum overnight to completely remove
organic solvents. The dry lipid film was then dispersed in PBS-buffer (or 20 mM
HEPES, pH 7.0 for FTIR experiments) and hydrated at a temperature well above
the gel to fluid phase transition of the respective phospholipid under intermittent
vigorous vortex-mixing following a protocol depending on the respective
phospholipid. The lipid concentration was 0.1 wt.% for calorimetric and
fluorescence spectroscopy experiments, 1.5 wt.% for FTIR spectroscopy and
5 wt.% for the X-ray measurements. LF11 was added to the dry lipid film
together with PBS at a lipid to peptide molar ratio of 25:1, while C12LF11 was
dissolved in organic solvent and added at the same molar lipid to peptide ratio
before drying the lipid. Identical hydration protocols were applied for liposomes
with and without peptide. The fully hydrated samples were stored at room
temperature until measurement (maximum up to 2 h).
Table 1
Minimal inhibitory concentration (MIC) of LF11 and C12LF11 (μg/ml)
Peptide MRSA ATCC
33591
E. coli ATCC
25922
P. aeruginosa ATCC
27853
LF11 >250 256 >500
C12LF11 62 64 62
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DSC experiments were performed with a differential scanning calorimeter
(VP-DSC), from MicroCal, Inc. (Northampton, MA, USA). Samples were
degassed before measuring. Heating scans were performed at a scan rate of
30 °C/h with a final temperature approximately 10 °C above the main transition
temperature (Tm) and cooling scans at the same scan rate with a final temperature
about 20 °C below Tm. The heating/cooling cycle was repeated twice, pre-scan
thermostating was allowed for 15 min for the heating scans and 1 min for the
cooling scans. Enthalpies were calculated by integrating the peak areas after
normalization to phospholipid concentration and baseline adjustment using the
MicroCal Origin software (VP-DSC version).
2.5. Small- and wide-angle X-ray scattering (SWAXS)
X-ray scattering experiments were performed on a SWAX-camera (HECUS
X-ray systems, Graz, Austria) allowing simultaneous recording of diffraction
data in both the small and the wide-angle region [33], which was mounted on a
rotating-Cu-anode X-ray generator (Rigaku-Denki) operating at 4 kW. CuKα-
radiation (λ=1.542 Å) was selected using a Ni-filter in combination with a pulse
height discriminator. The camera was equipped with a Peltier-controlled
variable-temperature cuvette (temperature resolution 0.1 °C) and two linear one-
dimensional position-sensitive detectors OED 50-M covering both small and
wide angle, regimes of interest. Calibration of the small-angle X-ray scattering
(SAXS) patterns was performed with silver stearate, p-Br benzoic acid and
Lupolen (solid polyethylene) were used to calibrate the wide-angle X-ray
scattering (WAXS) patterns. A programmable temperature and time controller
(HECUS X-ray systems, Graz, Austria) was used for temperature control
and data acquisition. After equilibration of the samples for 10 min at the
respective temperature, diffractograms for the small-angle region were
recorded with total exposure times of 7200 s for the small angle regime
and of 1800 s for the wide-angle region.
The phosphate–phosphate-distance, dpp, was derived from the SAXS
patterns using a global analysis technique described by Pabst et al. [34,35],
where the paracrystalline theory was applied for those gel phase patterns that
exhibited Bragg reflections. The domain size was calculated as product of the d-
spacing (d) and the average number of lamellae (Nmean) obtained from the global
fit.
2.6. FTIR spectroscopy
The infrared spectroscopic measurements were performed on an IFS-55
spectrometer (Bruker, Karlsruhe, Germany). The samples were placed in a
CaF2 cuvette with a 12.5 μm teflon spacer. Temperature-scans were
performed automatically between 10 and 70 °C with a heating-rate of
0.6 °C/min. Every 1–3 min, 50 interferograms were accumulated, apodized,
Fourier-transformed, and converted into absorbance spectra. For strong
absorption bands, the band parameters (i.e., peak position, band width, and
intensity) were evaluated from the original spectra, if necessary after
subtraction of the strong water bands.
2.7. Fluorescence spectroscopy
Fluorescence spectroscopy experiments were performed using a SPEX
Fluoro Max-3 spectrofluorimeter (Jobin-Yvon, Longjumeau, France) and
spectra were analysed with the Datamax software. Tryptophan fluorescence
spectra were obtained at room temperature (25 °C) using an excitation
wavelength of 282 nm and a slit width of 5 nm for both excitation and emission
monochromators. Peptides were diluted to 20 μg/ml in pure PBS or PBS
containing the respective phospholipids as unilamellar liposomes at a lipid to
peptide molar ratio of 25:1.
Quenching of Trp was carried out in the presence and absence of
phospholipid liposomes using 0.1, 0.4 and 0.7 M acrylamide. The data were
analyzed according to the Stern–Volmer equation [36]:
F0=F ¼ 1þ KSV½Q
where F0 and F represent the fluorescence emission intensities in the absence
and presence of the quencher molecule (Q), respectively, and KSV is the collisionStern–Volmer quenching constant, which is a quantitative measure for the
accessibility of tryptophan to acrylamide [37].
2.8. Optical microscopy
Phase contrast microscopy was performed on an inverted microscope
equipped with Zeiss Plan-Neofluars, Ph 40× and 63× oil, respectively. Diluted
samples were placed into a custom made specimen chamber that could be
thermostated and was made of stainless steel with a glass window of 0.16 mm
thickness and an optical path length of 2 mm within the sample.
3. Results
3.1. Biological activity
Representative results on the antimicrobial activities of
both LF11 and C12LF11 towards prominent Gram-positive
(methicillin-resistant Staphylococcus aureus, MRSA ATTC
33591) and Gram-negative bacterial strains (Escherichia coli
ATCC 25922, and Pseudomonas aeruginosa ATCC 27853,
respectively) are given in Table 1. LF11 exhibited no
substantial antimicrobial activity and no hemolytic activity
under the experimental conditions. In contrast, addition of the
acyl chain to the N-terminal part of LF11 was found to
strongly increase the antimicrobial activity towards all
bacterial strains tested. Strong hemolytic activity was found
at 100 μg/ml of peptide when tested under stringent
conditions (i.e. 0.25% of human red blood cells in the
hemolysis assay). This shows that the acylated peptide is able
to interact also with mammalian membranes.
3.2. Differential scanning calorimetry of bacterial and
mammalian model membranes
To correlate the variations in biological activities with the
interaction of LF11 and C12LF11 with membranes two
liposome systems were used: DPPG, which represents the
negatively charged component of bacterial cytoplasmic mem-
branes and DPPC, a zwitterionic component, typical of mam-
malian plasma membranes.
In agreement with published data [38,39], the temperature-
dependence of the excess heat capacity of pure DPPG showed
two phase transitions (Fig. 1), which can be attributed to the
pre-transition from the lamellar-gel (Lβ′ ) to the ripple-phase
(Pβ′ ) at 32.8 °C and the main or chain-melting transition from
the Pβ to the fluid (Lα) phase at 40.2 °C. Addition of LF11
(25:1 lipid to peptide molar ratio) resulted in a strong decrease
of the pre-transition enthalpy (ΔHpre) of DPPG (Fig. 1 and
Table 2), whereas the main transition was unaffected. In
contrast, addition of C12LF11 (25:1 lipid to peptide molar
ratio) did not only abolish the pre-transition but had also a
Fig. 1. DSC thermograms of DPPG in the absence and presence of LF11 or
C12LF11 (25:1, lipid to peptide molar ratio). For clarity, the DSC curves were
displayed on the ordinate by an arbitrary increment. The pre-transition is shown
enlarged in the inset. Scan rate was 30 °C/h.
Fig. 2. DSC thermograms of DPPC in the absence and in the presence of LF11 or
C12LF11 (25:1, lipid to peptide molar ratio). For clarity, the DSC curves were
displaced on the ordinate by arbitrary units. The pre-transition is shown enlarged
in the inset. Scan rate was 30 °C/h.
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In addition, a decrease in melting cooperativity was observed
in the presence of C12LF11 as indicated by the increased
transition half-width (ΔT1/2), as well as a destabilization of the
gel phase as indicated by a lower main transition temperature
(Tm) (Table 2).
The excess heat capacity curve of pure DPPC showed two
transitions (Fig. 2), which can be attributed to the pre-transition
at 34.8 °C and the main transition at 41.1 °C (Table 2), in
agreement with published data [40]. In contrast to DPPG,
addition of LF11 to DPPC (25:1 lipid to peptide molar ratio,
Fig. 2) only showed a slight reduction of ΔHpre. On the other
hand, similar effects as in DPPG were observed upon addition
of C12LF11 (1:25, Fig. 2), i.e., suppression of the pre-transition
and a marked decrease of both ΔHm and Tm as well as a strong
increase of ΔT1/2 (Table 2).
3.3. Small and wide angle X-ray scattering
The small-angle X-ray scattering pattern of DPPG liposomes
in the absence of peptides in the Lβ' phase (25 °C, i.e., below theTable 2
Thermodynamic data of phospholipid phase transitions in the absence and
presence of LF11 and C12LF11 at a lipid to peptide molar ratio of 25:1
ΔHpre
(kcal/mol)
Tpre
(°C)
ΔHm
(kcal/mol)
Tm
(°C)
ΔT1/2
(°C)
DPPG 1.5 32.8 9.9 40.2 0.46
+LF11 0.2 32.9 10.4 40.2 0.46
+C12LF11 0 – 7.6 39.5 1.56
DPPC 1.7 34.8 8.8 41.1 0.18
+LF11 1.4 34.7 8.1 41.1 0.18
+C12LF11 0 – 6.4 40.4 1.01pre-transition temperature) shows three weak lamellar diffrac-
tion orders with a lattice spacing d=118 Å, indicating a highly
swollen lamellar system (Fig. 3). Compared to multilamellar
dispersions of DPPC, the Bragg peaks are very broad and the
scattering domain size of 470 Å shows that under these
experimental conditions DPPG forms oligolamellar vesicles
(Nmean ∼ 4) within which the bilayers are positionally onlyFig. 3. SAXS- and WAXS-pattern (inset) of DPPG at 25 °C in the absence and
presence of either LF11 or C12LF11, where grey circles represent experimental
data and lines the calculated data. For clarity, the diffractograms are displaced on
the ordinate by arbitrary units.
Fig. 4. SAXS- and WAXS-pattern (inset) of DPPC at 25 °C in the absence and
presence of either LF11 or C12LF11, where grey circles represent experimental
data and lines the calculated data. For clarity, the diffractograms are displaced on
the ordinate by an arbitrary increment.
Table 3
Effect of LF11 and C12LF11 on the phosphorus–phosphorus distance (dpp) of
DPPG in the gel (25 °C) and fluid (50 °C) phase and DPPC in the gel phase
(25 °C)
Temperature (°C) Sample dpp (Å)
25 DPPG 44.4
+LF11 (25:1) a 41.1
+C12LF11 (25:1) 44.7
50 DPPG 37.0
+LF11 (25:1) 36.5
+C12LF11 (25:1) 37.8
25 DPPC 44.4
+LF11 (25:1) 43.4
+C12LF11 (25:1) 45.1
a Lipid to peptide molar ratio.
Fig. 5. Effect of LF11 and C12LF11 (lipid to peptide molar ratio of 5:1) on the
main transition of DPPG and DPPC vesicles monitored by the peak position of
the symmetric stretching vibration of the methylene groups of the lipids acyl
chains. Full symbols correspond to pure lipids and open symbols to samples
containing the respective peptide.
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the charged bilayers, which are only partially shielded by the
sodium ions of the buffer. The bilayer itself is characterized by a
dpp distance of 44.4 Å (Table 3) in agreement with previous data
[41]. The wide-angle X-ray pattern (Fig. 3, inset) shows a sharp
reflection at 4.26 Å [39] and a shoulder at 4.15 Å, indicating a
tilt of the hydrocarbon chains towards nearest neighbours [42].
Above Tm, at 50 °C (data not shown), the SAXS pattern shows
broad diffuse scattering indicating a loss of positional
correlation between the layers [43].
Addition of LF11 (25:1 lipid to peptide molar ratio) (Fig. 3)
leads to a minor increase of the d-spacing (120 Å), but to a
significant increase of the half-width of the Bragg peak, such
that only the second order reflection can be observed. This
indicates a further loss of positional correlations, seen also in the
decrease of the domain size to 438 Å. A global fit to the
scattering data further yielded a decrease of dpp to 41.1 Å
compared to pure DPPG. The SAXS pattern in the fluid phase
(50 °C, data not shown) was typical for a bilayer transform
characterized by a diffuse scattering. The calculated dpp in the
fluid phase exhibited no such significant changes between pure
DPPG and in the presence of LF11 (37 vs. 36.5 Å, Table 3). In
the wide-angle region, DPPG liposomes with LF11 showed a
single relative sharp peak at 4.15 Å below the Tm characteristic
for a hexagonal packing of the hydrocarbon chains, i.e., the tilt
is lost. This may also explain the strong reduction of the pre-
transition observed by DSC (Fig. 1).
The SAXS pattern in the gel phase in the presence of
C12LF11 (25:1 lipid to peptide molar ratio) shows a complete
loss of the positional correlations between the bilayers (Fig. 3)
and the pattern corresponds to the Fourier transform of a single
bilayer [34]. The derived dpp value of 44.7 Å shows no sig-
nificant change as compared to pure DPPG (Table 3). Addition
of C12LF11 induced similar changes to the hydrocarbon chain
packing as observed for LF11. Again, a single Bragg peak at
4.19 Å is detected in the wide-angle region (Fig. 3 inset),
indicating a slightly decreased packing density as compared to
LF11. Further, the increase of the peak width suggests a loss of
correlation between the hydrocarbon chains. This is in accor-
dance with DSC results (strongly reduced ΔHm, low coopera-
tivity) which also suggest loss of order of the hydrocarbon chain
packing in the gel phase.
Table 4
Stern–Volmer quenching constant (KSV) of LF11 and C12LF11 in PBS and
DPPG membranes, respectively, and maxima of emission wavelength (λem, max)
at a lipid to peptide molar ratio of 25:1
Peptide KSV in PBS
[M−1] (λem, max)
KSV in DPPG liposomes
[M−1] (λem, max)
LF11 38.2 (352 nm) 5.0 (334 nm)
C12LF11 8.9 (339 nm) 3.6 (330 nm)
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liposomes (Fig. 4) showed sharp Bragg reflections up to the
5th order indicating the existence of multilamellar vesicles [44].
A lamellar repeat distance (d-spacing) of 64 Å was calculated
for the gel phase and 68 Å for the fluid phase (data not shown)
in accordance with published data [45]. The dpp was 44.4 Å,
whereas the maximum domain size of 1600 Å was resolution
limited, indicating that there are more than 25 bilayer stacks.
The wide-angle pattern (Fig. 4 inset) shows similar to DPPG a
sharp reflection at 4.25 Å and a broad shoulder indicative of a
Lβ-phase with hydrocarbon side-chains tilted relative to the
normal of the bilayer plane [42].
Addition of LF11 did not markedly affect neither the wide-
angle nor the small-angle X-ray scattering pattern (Fig. 4).
There was no alteration of the peak position (d=64 Å) and a
negligible effect on dpp (43.4 Å). Only a slight broadening of the
Bragg peaks was observed, suggesting a decrease of number of
lamellae per scattering domain due to the presence of the
peptide, which was confirmed by global analysis yielding a
decrease of domain size to 960 Å, which corresponds to a stack
of 15 bilayers.
In contrast, addition of C12LF11 dramatically affected the
small-angle and wide-angle scattering pattern indicating a
strong loss of positional correlations between layers and of
hydrocarbon chain packing and therefore a major disturbance of
membrane packing by the peptide. The position of the first order
Bragg peak was displaced to 85 Å, superimposed on a broadFig. 6. Light microscopy of DPPG vesicles without (A) and with polarization filter (B
of 25:1; Scale bar represents 10 μm.diffuse scattering curve. The dpp of 45.1 Å was not significantly
altered, whereas the domain size was further decreased to 850 Å
(stack of 10 bilayers) The strong diffuse background is in the
present case most likely due to a large number of positionally
uncorrelated bilayers, such as unilamellar vesicles. WAXS
showed a completely different pattern now exhibiting a broad
diffuse Bragg peak localized around 4.2 Å (Fig. 4 inset)
characteristic for a bilayer with low order of hydrocarbon chain
packing, again in agreement with DSC results.
3.4. FTIR spectroscopy
The variation of the peak position of the symmetric
stretching vibration νs(CH2) was monitored as a function of
temperature through the main phase transition of DPPG and
DPPC in the absence and presence LF11 and C12LF11,
respectively (lipid to peptide molar ratio of 5:1). Addition of
LF11 to DPPG (Fig. 5 middle) did not change significantly Tm
as also observed in DSC, but induces a clear decrease in the
wavenumber of the symmetric stretching vibration of the
methylene groups of the DPPG acyl chains in the gel as well as
fluid phase. This indicates a rigidification of the bilayer in both
phases. Furthermore, LF11 has a pronounced reducing effect on
the intensity of the anti-symmetric stretching vibration of the
negatively charged phosphate group of DPPG (not shown),
indicating its partial immobilization and thus interaction of
LF11 with the DPPG head group. C12LF11 (bottom) broadened
the phase transition range and exhibited an effect similar to
cholesterol in phospholipid membranes [46]. The peptide
enhanced namely the fluidity of the acyl chains in the gel
phase (higher wavenumbers), but decreased it in the Lα phase
(lower wavenumbers) (Fig. 5).
LF11 at a lipid to peptide molar ratio of 5:1 does neither
affect the transition curve of DPPC nor the wavenumbers (Fig. 5
top) showing that there is no essential interaction between the
peptide and lipid bilayer in accordance with DSC and X-ray) and in the presence of LF11 (C) or C12LF11 (D) at a lipid to peptide molar ratio
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shown) causes a reduction of Tm and broadens the phase
transition range especially at higher peptide concentrations in
agreement with DSC results. However, in contrast to DPPG
liposomes the wavenumbers were not significantly affected.
3.5. Fluorescence spectroscopy
The KSV in buffer provides an insight into the peptide
solubility, translating to aggregation, whereas the KSV in lipid
environment together with the shift of the maxima of the
respective emission wavelengths (λem, max for pure Trp 353 nm
[47]) provides insight into the depth of penetration of the single
Trp of the peptide into the membrane.
As shown in Table 4 analysis of acrylamide-quenching of
LF11 in PBS in the absence of lipid gave a Stern–Volmer
constant (KSV) of 38 M
−1. This suggests a complete exposure of
tryptophan at position 3 of the peptide to the polar environment
which demonstrates the absence of peptide aggregation. The
corresponding value for C12LF11 in PBS at the same
concentration is 9. This gives evidence for a lesser exposure
of tryptophan to the polar environment and, in turn, potential
aggregation of C12LF11. Addition of different amounts of the
quencher acrylamide to DPPG-liposomes containing LF11
(lipid to peptide molar ratio of 25:1) gave a KSV of 5 M
−1 and
a blue shift from 352 to 335 nm indicating a more hydrophobic
environment for the tryptophan residue in the presence of DPPG
than in buffer. A plausible explanation could be the change of
secondary structure due to the presence of the negatively
charged lipid that induces a peptide fold with a T-shaped
arrangement of a hydrophobic core, formed by Phe1, Trp3 and
Ile7, and two clusters of basic residues [48]. Moreover, LF11
may to some extent dip into the bilayer interface as suggested
from the FTIR experiments being in accordance with the
reduced accessibility by the quencher molecule. An even lesser
accessibility by acrylamide and stronger hydrophobic environ-
ment of Trp was observed for C12LF11, when added to DPPG
liposomes. The quenching experiments yield a KSV of 3.6 M
−1
and a blue shift from 339 to 330 nm was observed. Both
parameters are characteristic of an increase of the non polar
environment of the tryptophan residue and indicate a stronger
penetration of the peptide into the hydrophobic core of the
DPPG membrane.
3.6. Optical microscopy
As can be seen in Fig. 6A the preparation of DPPG vesicles
in PBS diluted from the X-ray samples to a concentration of
50 μg/ml gave predominantly OLVs (oligolamellar vesicles)
(dark little dots) up to 1 μm and some MLVs (multilamellar
vesicles) in the size range of 10 μm. Some bright spots may
indicate the existence of ULVs (unilamellar vesicles). MLVs
can be clearly observed as Maltese crosses under crossed
polarizers (Fig. 6B). It has to be emphasized that the distribution
of vesicles is not representative since MLVs are heavier and will
therefore be more concentrated in the lower regions of the
sample chamber, the field of observation. Addition of thepeptides LF11 (Fig. 6C) and C12LF11 (Fig. 6D) to DPPG
results in strong reduction of MLVs. These observations
correlate with our X-ray-data. In case of LF11 some aggregated
vesicles were observed, while in the presence of C12LF11
basically all vesicles found are aggregates, with aggregate sizes
of up to 50 μm.
4. Discussion
Electrostatic interactions between a cationic peptide and
anionic phospholipids initially favor binding of the peptide to
the membrane surface, which is the generally agreed hypothesis
concerning antimicrobial peptide selectivity [23]. This is also
reflected in the biophysical studies on the interaction of LF11
with negatively charged DPPG and zwitterionic DPPC bilayers,
respectively. The calorimetric, X-ray and FTIR data demon-
strate that DPPC membranes remain unperturbed by LF11
showing that this peptide does not interact with this bilayer in
accordance with the non-hemolytic activity of LF11. On the
other hand, from the DSC thermograms, it is clear that although
LF11 does not affect the main transition of DPPG liposomes
appreciably, both in terms of enthalpy and transition tempera-
ture, the enthalpy of the pretransition is reduced by 80%. This
indicates the occurrence of interference of the peptide with
DPPG bilayers in agreement with observations from X-ray
scattering, fluorescence and FTIR experiments. The latter
shows that the peptide binds to the phosphate of the lipid
headgroup, which is consistent with acrylamide quenching
experiments that give evidence that the tryptophan residue is
buried at least in the interface of the bilayer. Furthermore, X-ray
data indicate a slight but significant thinning of the membrane in
the gel phase as deduced from the reduced P–P distance in the
presence of LF11 going hand in hand with a rearrangement of
the hydrocarbon chains and a rigidification of these chains as
seen by FTIR spectroscopy.
Membrane thinning was also observed upon addition of
other antimicrobial peptides to lipid bilayers such as e.g., PGLa
[44], melittin [49], alamethicin [50], magainin-2 [51], or MSI-
78 [52]. They all have in common that the peptides induce a
membrane thinning of 1–3 Å, which Ludtke et al. [51]
explained by the adsorption of peptide molecules to the
headgroup region that forces a gap in the chain region to be
filled where the membrane must become locally thinner. In their
model they approximate this as uniform thinning over the entire
membrane. Mecke at al. [52] also supposed that MSI-78, an
anologue of magainin-2, binds to DMPC bilayers forming
distinct domains with in places (not uniform) reduction of
bilayer thickness up to 11 Å. So it is conceivable that insertion
of LF11 into the negatively charged membrane on the one side
of the bilayer induces such a gap that is compensated by the
hydrophobic chains of the opposite monolayers of the bilayer
causing the observed overall membrane thinning. Nevertheless
the antimicrobial activity of LF11 is weak, which may be due to
the low overall hydrophobicity of the peptide.
Using combinatorial libraries analogs of a cationic amphi-
pathic peptide were identified in which hydrophobic residues
inserted into the hydrophilic face have resulted in a greater
Fig. 7. Schematic representation of insertion of C12LF11 into DPPCmembranes
indicating the void formed within the hydrophobic core of the bilayer. Lipid and
peptide are to scale, whereby the peptide structure is based on NMR data
(manuscript in preparation).
1433D. Zweytick et al. / Biochimica et Biophysica Acta 1758 (2006) 1426–1435therapeutic index than the original peptide [23,53]. Similarly,
acylation of weakly or inactive peptides may compensate for
lack of hydrophobicity [24] and favor membrane insertion and
thus membrane permeation [54,55]. In fact, some potent
antimicrobial peptides of bacterial and fungal origin like
echinicandin [56], polmyxins [57], or daptomycin [58] contain
fatty acids. It has been postulated that acylation of proteins
helps to increase their membrane association and sorting into
specific subcellular localization [56,59]. Furthermore, reports
have shown that removal of the acyl chain of polymyxin B
causes a decrease in its LPS-neutralizing potency and lower
antimicrobial activities [60–62]. This suggests that addition of
an acyl chain to an antimicrobial peptide should result in
stronger antimicrobial activity. In fact, several studies to assess
the effect of acylation have demonstrated that conjugation of
fatty acids to cationic peptides enhances their antimicrobial
activity [25,54,63–65].
This was also observed upon N-acylation of LF11 that
dramatically enhanced the effect of the peptide as shown in the
biological activity assays as well as in membrane model
systems. However, as can be deduced from the obtained data,
C12LF11 is now able to penetrate the membrane independently
on the charge of the headgroup, although binding and depth of
membrane penetration of C12LF11 may vary depending on the
nature of the phospholipid headgroup. Hydrogen exchange
protection in NMR experiments showed that in anionic micelles
LF11 is less deeply inserted into the hydrophobic core than in
zwitterionic micelles indicating the decreasing extent of inser-
tion of the N terminus and potential role of peptide plasticity in
differentiation between bacterial and eukaryotic membranes
[48]. Nevertheless, the lauryl group of the peptide will penetrate
into the hydrophobic core of the membrane strongly perturbing
the lipid packing of both DPPG and DPPC bilayers. A loss of
chain correlation is evident from the wide-angle X-ray pattern
as well as reduction of ΔHm. The decrease of Tm further
indicates the destabilization of the gel phase. These observa-tions can be explained by the creation of voids in the
hydrophobic core of the membrane as schematically shown in
Fig. 7. This can arise due to both the hydrophobic mismatch of
the acyl chains of the peptide (C12) and lipids (C16), as has
been described for the interaction of small amphipathic
molecules such as fatty acids or detergents [66], and the
insertion of the hydrophobic amino acid cluster (Phe1, Trp3) in
the membrane interface. This is energetically an unfavorable
situation and hence the system will rearrange in a way that
hydrophobic interactions are maximized, i.e., by disordering of
the hydrocarbon chains to fill the void. Although DSC and X-
ray studies showed the same effects of C12LF11 on both
membrane model systems, FTIR spectroscopy experiments
indicated some differences in the kind of perturbation of the
hydrocarbon chains. While the rigidity of the acyl chains of
DPPC was not markedly affected by C12LF11, a cholesterol
like effect (increase of fluidity below and a decrease of fluidity
above Tm) was observed for the C12LF11/DPPG system. This
may be explained by a different structural arrangement of the
N-lauryl chain, when inserted into zwitterionic or negatively
charged membrane systems. Indeed 2D-NMR experiments
revealed that in zwitterionic DPC (dodecylphosphocholine)
micelles the structure of the N-acyl chain was not well defined,
while in negatively charged SDS micelles, the hydrophobic
chain makes a sharp turn towards the peptide backbone
(manuscript in preparation). Such a bend structure of the
N-lauryl chain together with the aromatic residues of Phe1
and Trp3 could mimic to some extent the rigid ring structure
of cholesterol.
Pre-assembly of the acylated peptide in solution as indicated
by fluorescence spectroscopy experiments may also be a factor
for the unspecific interaction between C12LF11 and membrane
model systems as suggested earlier [67]. For example, cova-
lently linked pentameric bundles of diastereomeric cationic
peptides exhibited independent on the peptide length (13,16,19
amino acid residues) high activity towards fungi, bacteria and
red blood cells, while the monomeric peptides showed length-
dependent antimicrobial activity and were devoid of hemolytic
activity [68].
Thus, electrostatic interactions seem to play an important
role for the membrane binding of the peptide but for penetration
a certain threshold value of hydrophobicity is needed, which
results in a stronger membrane perturbation. This is in accor-
dance with the great difference in activity observed between
LF11 and C12LF11. However, as described e.g., for PGLa [69],
membrane selectivity is caused predominantly by electrostatic
attraction of the peptide to the membrane surface and not by
hydrophobic insertion. Therefore, a certain balance within
electrostatic interaction and hydrophobicity is required for
specific and high activity towards bacterial membranes [10],
which has also been shown for other lipopeptides [24] and will
be a challenge for the future.
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